Microbubble-based focused ultrasound therapies provide a minimally invasive method to 1 deliver drugs into tissues, tumors, blood clots, and individual cells. Microbubbles are routinely 2 used in clinical ultrasound imaging as contrast agents and are currently being investigated as 3 intravascular stress sources to induce therapeutic bioeffects. 1 When exposed to the alternating 4 phases of an ultrasound field, they respond by expanding and contracting. These volumetric 5 oscillations, known as acoustic cavitation, can be harnessed to achieve a desired therapeutic effect, 
10
A defining factor determining the efficacy, safety and reversibility of BBB opening is the 11 selected therapeutic pulse shape and sequence, which affects the magnitude and distribution of 12 induced stresses in the brain microvasculature. Although ms-long pulses have been primarily used 13 to transiently open the BBB to date, μs-long pulses emitted at kHz pulse repetition frequencies
14
were also shown to result in high drug delivery rates within the targeted brain region. 5 Such rapid 15 short pulses have been shown to produce more uniform cavitation activity within the focal volume 16 in vitro, 6,7 while reducing microbubble interactions, acoustic radiation forces and clustering 17 formation observed during ms-long sonication.
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Regardless of the therapeutic design, a major advantage of microbubble-based ultrasound 19 therapies is the ability to passively monitor their evolution and capability of inducing a bioeffect 20 in real-time. Passive cavitation detection (PCD) provides information about cavitation magnitude, 21 duration, and mode, 6,10 but also the velocity of cavitation nuclei exposed to radiation forces. 11 PCD
22
can be performed using two separate co-aligned transducers 6,11 or a single transducer. 12 Using In vitro and in vivo experiments were conducted using the same experimental setup ( pulse, and partially due to non-linear ultrasound propagation.
13
In our previous work, 18 we used a high-frequency array (L22-14v) with a -6 dB bandwidth 14 between 12.6 and 24.8 MHz. This frequency range was higher than the therapeutic frequency (i.e., intraperitoneally. T1-weighted MR sequences were acquired in a small-animal 9.4 T MRI system 7 to confirm BBB opening and investigate Gd diffusion into the brain parenchyma.
8
All data are presented as mean ± s.d. (n = 10 for in vitro and n = 5 for in vivo experiments).
9
To evaluate statistically significant differences, we performed either parametric paired t-tests or 10 non-parametric Wilcoxon Rank tests, depending on the normality of the data (assessed with a two-11 sample F-test). Statistical significance was assumed at 0.05 p  .
12
To determine microbubble activation and detection sensitivity in free field, therapeutic ) and compare it to the focal size measured with a hydrophone.
21
Although normalization reduced the visible contour in Fig. 2(B) , the axial and lateral between 0.8 and 3.9 dB in the detected cavitation signal (suppl. Fig. 3 ). The effect of PI was 5 observed for pulses of arbitrary pulse length (e.g. 50 cycles, suppl. Fig. 4 ) and was similar between 6 synchronous and asynchronous passive imaging techniques (suppl. Fig. 5 ), providing evidence that 7 PI can improve the monitoring of any low-power therapeutic ultrasound application with a given 8 passive imaging system.
9
Our hypothesis in this study was that PI would increase the CTR by suppressing signals significantly suppressed during PI exposure [ Fig. 3(B) ].
16
To quantify the differences in CTR, we isolated two ROIs within the phantom based on B-17 mode images (suppl. Fig. 6 ), corresponding to bubble and tissue areas, respectively. The measured
18
CTR was consistently higher in PI exposure throughout the acoustic pressures which are relevant
19
to BBB opening applications [ Fig. 3(C) ]. Using PI, the CTR increased by up to 5.5 dB at low 20 acoustic pressures, which are preferable for safe and reversible BBB opening but difficult to 21 produce detectable microbubble activity in vivo. The CTR range was 5.6 to 9.9 with PI and 3.3 to indicating that PI is primarily effective in the low-power regime.
5
Non-linear ultrasound propagation was expected to be more pronounced at higher 6 pressures, leading to an increase of the harmonic content of the therapeutic pulse, including an 7 elevation of the second harmonic which is not suppressed by PI. Based on our data, the tissue amplitude. 11 We speculate that a decrease in the even harmonics would lead to a decrease in the 12 produced CTR.
13
The position of the tissue ROI distal to the microbubble population may have resulted in 14 a decrease of the acoustic pressure due to acoustic shielding effects. Furthermore, a pressure 15 decrease was expected throughout the bubble and tissue ROI due to ultrasound attenuation,
16
therefore the reported CTR values are an averaged approximation.
17
To test the potential of PI in BBB opening, we conducted a pilot in vivo study. Control Therapeutic PI sequences significantly increased the CTR compared to no-PI sequences (Fig. 3) 11 without significant change of the therapeutic field (Fig. 2) resolution of the cavitation mapping (suppl. Fig. 4) . Furthermore, the broadband frequency content 7 of the microbubble emissions does not allow for meaningful spectral analysis. 
